A new facilitated solid phase extraction method for bioavailability evaluation of Lisinopril in fasting healthy male volunteers

Current Pharmaceutical Analysis

Volumn 8, Issue 4, 2012, Pages 431-439

  Foroozesh, Mahshid ^a   Hamidi, Mehrdad ^a,b   Shahbazi, Mohammad Ali ^a,c   Sahraei, Mohammad Ali ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ZANJAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Bioequivalence; Lisinopril; Reversed phase HPLC UV; Solid phase extraction

Indexed keywords

GENERIC DRUG; LISINOPRIL;

ACCURACY; ADULT; ANALYTIC METHOD; AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET RESTRICTION; DISTRIBUTION VOLUME; DOUBLE BLIND PROCEDURE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG ELIMINATION; DRUG ISOLATION; HUMAN; HUMAN EXPERIMENT; LIMIT OF DETECTION; LIMIT OF QUANTITATION; MALE; MAXIMUM PLASMA CONCENTRATION; MEAN RESIDENCE TIME; NORMAL HUMAN; PRIORITY JOURNAL; QUANTITATIVE ASSAY; RANDOMIZED CONTROLLED TRIAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SOLID PHASE EXTRACTION; STEADY STATE; TIME TO MAXIMUM PLASMA CONCENTRATION; ULTRAVIOLET SPECTROSCOPY; VALIDITY;

EID: 84867768986     PISSN: 15734129     EISSN: 1875676X     Source Type: Journal    
DOI: 10.2174/157341212803341672     Document Type: Article

References (16)

1. Arzubiaga, C.; Beck, N. A. Lisinopril, a new angiotensin converting enzyme inhibitor. Am. J. Med. Sci. 1992, 303 340-344.
2. Demers, C.; Mody, A.; Teo, K. K.; McKelvie, R. S. ACE inhibitors in heart failure: what more do we need to know? Am. J. Cardiovasc. Drugs 2005, 5 351-359.
3. Hamidi, M.; Shahbazi, M. A.; Azimi, K. Bioequivalence evaluation of a triamterene-hydrochlorothiazide generic product: a new bioequivalence index for fixed-dose combinations. Regul. Toxicol. Pharmacol. 2011, 59 149-156.
4. Hamidi, M.; Zarei, N.; Shahbazi, M. A. A simple and sensitive HPLC-UV method for quantitation of lovastatin in human plasma: application to a bioequivalence study. Biol. Pharm. Bull. 2009, 32 1600-1603.
5. Gopinath, S.; Kumar, R. S.; Alexander, S.; Danabal, P. Development and Validation of a Rapid and Sensitive Assay for Simultaneous Quantification of Lenalidomide and Dexamethasone in Human Plasma by Liquid Chromatography Coupled to Tandem Mass-Spectrometry. Curr. Pharm. Anal. 2011, 7 240-247.
6. Worland, P. J.; Jarrott, B. Radioimmunoassay for the quantitation of lisinopril and enalaprilat. J. Pharm. Sci. 1986, 75 512-516.
7. Yuan, A. S.; Gilbert, J. D. Time-resolved fluoroimmunoassay for the determination of lisinopril and enalaprilat in human serum. J. Pharm. Biomed. Anal. 1996, 14 773-781.
8. Leis, H. J.; Fauler, G.; Raspotnig, G.; Windischhofer, W. An improved method for the measurement of the angiotensin-converting enzyme inhibitor lisinopril in human plasma by stable isotope dilution gas chromatography/negative ion chemical ionization mass spectrometry. Rapid Commun. Mass Spectrom. 1999, 13 650-653.
9. Shin, M. C.; Kim, J. K.; Kim, C. K. Bioequivalence evaluation of two brands of lisinopril tablets by in vivo comparative dissolution test and in vivo bioequivalence test. Arzneimittelforschung 2008, 58 11-17.
10. Padua, A. A.; Barrientos-Astigarraga, R. E.; Rezende, V. M.; Mendes, G. D.; De Nucci, G. Lisinopril quantification in human plasma by liquid chromatography-electrospray tandem mass spectrometry. J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 2004, 809 211-216.
11. Zhou, N.; Liang, Y. Z.; Chen, B. M.; Wang, P.; Chen, X.; Liu, F. P. Development and validation of LC-MS method for the determination of lisinopril in human plasma and its application in a bioequivalence study. J. Chromatogr. Sci. 2008, 46 848-853.
12. Tamimi, J. J.; Salem, II; Alam, S. M.; Zaman, Q.; Dham, R. Bioequivalence evaluation of two brands of lisinopril tablets (Lisotec and Zestril) in healthy human volunteers. Biopharm. Drug Dispos. 2005, 26 335-339.
13. Sagirli, O.; Ersoy, L. An HPLC method for the determination of lisinopril in human plasma and urine with fluorescence detection. J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 2004, 809 159-165.
14. El-Emam, A. A.; Hansen, S. H.; Moustafa, M. A.; El-Ashry, S. M.; El-Sherbiny, D. T. Determination of lisinopril in dosage forms and spiked human plasma through derivatization with 7-chloro-4-nitrobenzo-2-oxa-1,3-diazole (NBD-Cl) followed by spectrophotometry or HPLC with fluorimetric detection. J. Pharm. Biomed. Anal. 2004, 34 35-44.
15. Doganm, A.; Basci, N. E. Development and Validation of RPHPLC and Ultraviolet Spectrophotometric Methods of Analysis for the Quantitative Determination of Chlorhexidine Gluconate and Benzydamine Hydrochloride in Pharmaceutical Dosage Forms. Curr. Pharm. Anal. 2012, 7 167-175.
16. Kit, C. W.; Segarra, I. Simultaneous HPLC Determination of Metronidazole and Spiramycin in Plasma and Brain of Mouse. Curr. Pharm. Anal. 2011, 7 262-267.